Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pyrithione zinc is an active antimicrobial compound used primarily to treat dandruff and seborrheic dermatitis of the scalp. It has antibacterial, antimicrobial, and antifungal properties that help control the symptoms of these conditions. The compound was rationally developed, modeled after the naturally occurring antimicrobial aspergillic acid. Its efficacy stems from its broad antimicrobial spectrum of activity against fungi, gram-positive and gram-negative bacteria, combined with its low solubility. This low solubility results in formulation as a particulate material that deposits and is retained on skin surfaces, functioning as slow-release reservoirs to provide extended and persistent benefits.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pyrithione zinc.